The Last Great Value Stock
Last year it was more profitable than Disney, Square or even Tesla.

But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.
>>>
Scott William Drake, insider at ViewRay

Scott William Drake Insider Information

CEO of ViewRay
Scott William Drake serves as Independent Chairman of the Board of the Company. Mr. Drake has served as one of our directors since September 2013 and as the Chairman of the Board since May 2018. Mr. Drake currently serves as the President and Chief Executive Officer of ViewRay, a publicly-held medical device company with global operations in radiation therapy and imaging technologies. Previously, Mr. Drake was the President, Chief Executive Officer, and member of the Board of Directors of The Spectranetics Corporation from 2011 to 2017. Spectranetics, acquired by Royal Philips in August of 2017, was a publicly-held medical device company that developed, manufactured and distributed single-use medical devices used in minimally invasive procedures within the cardiovascular system. Prior to joining Spectranetics, Mr. Drake served as Senior Vice President, Operations, of DaVita, Inc., a leading U.S. provider of kidney care and dialysis. Previously, Mr. Drake spent 17 years in several leadership positions within numerous healthcare business units at Covidien. From 2006 to 2009, he was President of Covidien’s Respiratory and Monitoring Solutions Global Business Unit, a $1.5 billion business with 8,000 employees. Mr. Drake has also served on the Board of Directors for The Zayo Group Holdings, Inc. since November 2018. Mr. Drake is Chairperson of the AdvaMed Radiation Therapy Sector and a board member of the Medical Device Manufacturers Association (MDMA). Mr. Drake earned a B.S. in Business Administration from Miami University of Ohio.

What is Scott William Drake's net worth?

The estimated net worth of Scott William Drake is at least $11.70 million as of May 10th, 2022. Mr. Drake owns 3,994,730 shares of ViewRay stock worth more than $11,704,559 as of May 18th. This net worth approximation does not reflect any other investments that Mr. Drake may own. Additionally, Mr. Drake receives an annual salary of $1,410,000.00 as CEO at ViewRay. Learn More about Scott William Drake's net worth.

How old is Scott William Drake?

Mr. Drake is currently 54 years old. There are 4 older executives and no younger executives at ViewRay. Learn More on Scott William Drake's age.

What is Scott William Drake's salary?

As the CEO of ViewRay, Inc., Mr. Drake earns $1,410,000.00 per year. Learn More on Scott William Drake's salary.

How do I contact Scott William Drake?

The corporate mailing address for Mr. Drake and other ViewRay executives is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. ViewRay can also be reached via phone at (440) 703-3210 and via email at [email protected] Learn More on Scott William Drake's contact information.

Has Scott William Drake been buying or selling shares of ViewRay?

Over the course of the past ninety days, Scott William Drake has bought $104,400.00 in shares of ViewRay stock. As an example of a recent trade by , 0 shares of the firm's stock in a transaction on Wednesday, May 18th. Learn More on Scott William Drake's trading history.

Who are ViewRay's active insiders?

ViewRay's insider roster includes Scott Drake (CEO), and Zachary Stassen (CFO). Learn More on ViewRay's active insiders.

Are insiders buying or selling shares of ViewRay?

During the last twelve months, ViewRay insiders bought shares 8 times. They purchased a total of 1,372,142 shares worth more than $3,952,395.20. During the last twelve months, insiders at the sold shares 2 times. They sold a total of 8,300,000 shares worth more than $53,751,000.00. The most recent insider tranaction occured on May, 11th when Director Caley Castelein bought 1,065,000 shares worth more than $2,705,100.00. Insiders at ViewRay own 4.8 % of the company. Learn More about insider trades at ViewRay.

Information on this page was last updated on 5/11/2022.

Scott William Drake Insider Trading History at ViewRay

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2022Buy40,000$2.61$104,400.003,994,730View SEC Filing Icon  
11/19/2021Buy89,285$5.60$499,996.00View SEC Filing Icon  
11/10/2020Buy155,000$3.23$500,650.00View SEC Filing Icon  
8/13/2019Buy131,260$3.81$500,100.60View SEC Filing Icon  
11/13/2018Buy60,000$6.47$388,200.00View SEC Filing Icon  
See Full Table

Scott William Drake Buying and Selling Activity at ViewRay

This chart shows Scott William Drake's buying and selling at ViewRay by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ViewRay Company Overview

ViewRay logo
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
Read More

Today's Range

Now: $2.93
Low: $2.88
High: $3.15

50 Day Range

MA: $3.41
Low: $2.42
High: $4.10

2 Week Range

Now: $2.93
Low: $2.39
High: $8.25

Volume

1,415,861 shs

Average Volume

1,644,107 shs

Market Capitalization

$528.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12
Invest in Artificial Intelligence Before It Changes the World
A.I. is going to be one of the dominant themes over the next decade, as companies automate their businesses and use A.I. to remain competitive. This is the golden age of investing in artificial intelligence!
Invest in this red-hot industry at pre-IPO prices.